The announcement was made after market hours yesterday, 6 February 2019.
Meanwhile, the S&P BSE Sensex was up 114.20 points, or 0.31% to 37,089.43
On the BSE, 2,113 shares were traded in the counter so far compared with average daily volumes of 900 shares in the past two weeks. The stock had hit a high of Rs 1,825 and a low of Rs 1,672 so far during the day.
AstraZeneca Pharma India's net sales rose 67.41% to Rs 215.19 crore in Q3 December 2018 over Q3 December 2017.
AstraZeneca Pharma India is the operating company covering manufacturing, sales and marketing activities. It has an innovative portfolio to address the unmet needs in non-communicable diseases such as diabetes, heart disease, cancer, asthma & COPD.